MIAX options trading volume rises 26.6% year to date

MIAX reported YTD March 2026 ADV of 10.9M contracts, up 26.6% YoY (March ADV 10.7M, +29.4% YoY) and captured a 17.3% share of U.S. multi-list options vs 16.0% a year earlier. Analysts forecast FY2026 EPS of $1.68 (vs an LTM loss of $1.00), and MIAX beat Q4 2025 with adjusted diluted EPS $0.52 vs $0.33 expected and revenue $125M (+52% YoY). Offsetting strength, MIAX Futures volumes fell sharply (March -29.4% to 10,394 contracts; YTD -39.9%), and MIAX Pearl Equities ADV rose to 194M shares (+18.7% YoY) with a 0.9% U.S. equities market share. Governance update: director Lee Becker will not stand for reelection at the 2026 annual meeting.

Analysis

MIAX’s recent volume and mix moves create an outsized operating-leverage opportunity: options flow growth is a high-margin, scaleable revenue stream (data + transaction fees + clearing ancillary services) so each incremental point of market share should flow disproportionately to EBITDA if tech and clearing fixed costs are already sunk. The less obvious lever is market-data bundling — MIAX can tack on incremental per-seat/data fees to HFTs, market makers and sell‑side firms who already route options flow there, creating annuity-like revenue that compresses churn risk from pure taker fees.

A material headwind is the structural decline in futures volumes: persistent weakness there signals either client migration to competitors with better clearing/market access or product-level commoditization that will blunt cross‑product synergies. Regulatory shifts (maker‑taker, SIP/data reforms) or a meaningful normalization in retail/volatility could reverse the re‑rating quickly; these are 0–3 month catalysts for price action, while execution of data monetization and margin expansion plays out over 6–18 months.

Consensus appears to price a clean transition from volume growth to durable margin expansion — that’s the second‑order risk. If you believe MIAX can meaningfully expand data/clearing ARPU, use option structures to get long convexity to an earnings/12‑18 month re‑rating; if you worry about multiple compression from valuation or regulatory shocks, prefer short/hedged exposure or pair trades versus larger incumbents to isolate share gains from broad exchange beta.

Key Decisions for Investors

• Long MIAX equity + buy protective put (ticker: MIAX). Timeframe: 6–12 months. R/R: target 25–35% upside if ARPU/EBITDA beats; limit downside to ~12% via put hedge to protect against multiple contraction from regulatory/news risk.
• Calendar/Diagonal call spread on MIAX (long 12–18mo calls, sell near‑term calls). Timeframe: 6–18 months. R/R: asymmetric upside to capture multi‑quarter margin expansion while funding premium with nearer-term sells; stop/roll if implied vol > realized by 30% over a month.
• Pair trade: long MIAX (1.0) / short CBOE (CBOE) (0.6–0.8 dollar‑neutral). Timeframe: 6–12 months. R/R: play continued share gains vs incumbent; target 20–30% relative outperformance, stop if MIAX underperforms peer by 10% absolute or on earnings/methodology miss.
• Tactical short or put on MIAX futures-facing exposure (ticker: MIAX). Timeframe: 3–6 months. R/R: buy 3–6mo puts sized ~25–35% of equity exposure to hedge against continued futures-venue erosion or regulatory fee shocks; take profits on signs of margin contraction or policy headlines.
• Covered-call monetize if long and conviction medium: buy MIAX equity, sell 3–6 month calls at ~15–20% OTM. Timeframe: 3–6 months. R/R: generates yield on sideways base while participating in moderate upside; roll or unwind if volumes and realized spreads accelerate beyond premium capture.